Tandem Diabetes Care, Inc. (TNDM)
Makes insulin pumps that automatically deliver the right dose for people with diabetes.
$17.58+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+14.2%
The outlook
TNDM is trading near the lower end of its 52-week range, with analyst consensus solidly bullish and an average price target roughly 65% above the current level. The stock's trend versus moving averages is mixed, suggesting some near-term uncertainty despite the overall analyst lean toward buying.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 19 analysts
Price trendMixed vs its moving averages
52-week range39% of the way from its 52-week low to high
Price targetAvg target +65% vs current price
Analyst price target
~12-month · 19 analysts$29.08average target+65.4% vs now
Now $17.58
Low $15.50High $50.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.20B
52-wk high
$29.65
52-wk low
$9.98
50-day avg
$16.11
200-day avg
$18.93
Trailing P/E
—